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background: Serum lactonase activity is inversely related to systemic oxidative stress and negatively correlates with atherogenic cardiovascular 
risk. The prognostic utility of serum lactonase activity (SLA) in patients with heart failure is unknown. We hypothesize SLA will predict all-cause 
mortality in patients with stable heart failure.
Methods: Serum lactonase activity levels were measured in 533 consecutive stable patients, with heart failure undergoing elective diagnostic 
coronary angiography without acute coronary syndrome, with 5-year follow-up of all-cause mortality. We measured aminoterminal pro B-type 
natriuretic peptide (NT-proBNP, Roche). Serum lactonase activity was quantified by hydrolysis rate of gamma-thiobutyrolactone.
results: In our cohort (mean age 67±11 years, 64% male, 40% diabetic, 72% with history of coronary artery disease [CAD], median NT-proBNP 
1,339 pg/mL, and median GFR 70.4 mL/min), the median SLA was 133.5 μmol/min/mL [IQR 105.4, 162.3] and 190 patients died by 5-years. 
Lower SLA independently predicted a 1.8-fold increased 5-year mortality (stratified at median: Hazard ratio [95% confidence interval] 1.76 [1.32-
2.37], p=0.0001, Figure). After adjusting for NT-proBNP, GFR, and history of CAD lower SLA predicted a 1.4-fold increase in mortality (1.42 [1.04-
1.95], p=0.026).
conclusions: Diminished serum lactonase activity levels provide independent and incremental prognostic value for mortality prediction in stable 
heart failure patients.
 
